Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives.
Ciloa has raised €6.5M across 1 funding round from 3 investors, most recently a round in Jul 2025. Based in Montpellier, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-09 | Other | €6.5M |
| Bpifrance,France 2030 ‘Biotherapies and Biomanufacturing of Innovative Therapies’ ,French Government |
| View deal → |
